- 恒指
- 26,214
- +315
- 大市成交 3,047億
- 即時昭衍新藥
- 39.700+0.830 (+2.135%)
盈利能力分析
- 2.824
- 3.631
- 0.906
- 4.823
- 14.024
- 2.418
- 3.122
- 0.763
- 3.894
- 11.367
- 2.497
- 3.236
- 0.790
- 4.089
- 11.932
邊際利潤分析
- 20.486
- 20.711
- 28.428
- 42.617
- 47.898
- 80.953
- 20.390
- 5.170
- 21.338
- 54.041
- 76.942
- 16.330
- 0.211
- 14.974
- 47.854
- 75.395
- 17.968
- 3.456
- 16.476
- 47.320
收益指標分析
- -7.067
- -1.656
- 244.702
- 148.826
- 68.484
- 112.318
- 137.951
- -87.503
- -46.556
- 29.241
- 0.053
- -0.148
- -0.296
- -0.029
- 1.158
償債能力分析
- 4.017
- 4.534
- 4.530
- 4.854
- 3.215
- 2.778
- 3.317
- 3.199
- 3.584
- 2.025
- 14.743
- 14.011
- 14.016
- 17.414
- 20.970
- 10.184
- 8.599
- 8.792
- 11.435
- 12.762
- 859.986
- 1,038.452
- 1,011.605
- 749.269
- 657.404
- 578.260
- 613.684
- 613.442
- 474.155
- 376.548
- -18.979
- -4.052
- -0.043
- -2.355
- -7.016
營運能力分析
- 51.918
- 39.341
- 34.530
- 30.710
- 24.369
- 532.623
- 395.906
- 416.385
- 535.589
- 441.019
中東戰火
大國博弈
More